Related Articles
Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection
Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin
Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapy
Combined IFN-α and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus
Clinical efficacy of the highly sensitive hepatitis C virus RNA quantitative assay in patients with relapse following interferon‑based therapy with second‑generation direct‑acting antivirals